Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate

Transfusion

Volumn 49, Issue 4, 2009, Pages 696-703

  Cardigan, Rebecca ^a   Philpot, Katherine ^b   Cookson, Philip ^b   Luddington, Roger ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; METHYLENE BLUE; THROMBIN;

ARTICLE; BLOOD CLOTTING; BLOOD EXAMINATION; CLOT FIRMNESS; CRYOPRECIPITATE; HEMATOLOGICAL PARAMETERS; PLASMA; ROTATIONAL THROMBELASTOMETRY;

ALGORITHMS; BLOOD; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD PRESERVATION; COLD TEMPERATURE; FACTOR VIII; FIBRINOGEN; HEMATOLOGIC AGENTS; HUMANS; METHYLENE BLUE; PROTEIN STABILITY; THROMBIN;

EID: 62949136117     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.02039.x     Document Type: Article

References (24)

1. Wagner SJ. Virus inactivation in blood components by photoactive phenothiazine dyes. Transfus Med Rev 2002 16 : 61 6.
2. Williamson LM, Cardigan R, Prowse CV. Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion 2003 43 : 1322 9.
3. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Béguin S. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002 32 : 249 53.
4. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005 27 : 81 90.
5. Guidelines for the Blood Transfusion Services in the United Kingdom. 7th ed. London : The Stationary Office 2007.
6. Falls LA, Furie B, Furie BC. Role of phosphatidylethanolamine in assembly and function of the factor IXa-factor VIIIa complex on membrane surfaces. Biochemistry 2000 39 : 13216 22.
7. Butenas S, van't Veer C, Mann KG. Normal thrombin generation. Blood 1999 94 : 2169 78.
8. Zeiler T, Riess H, Wittmann G, Hintz G, Zimmermann R, Müller C, Heuft HG, Huhn D. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion 1994 34 : 685 9.
9. Riggert J, Humpe A, Legler TJ, Wolf C, Simson G, Köhler M. Filtration of methylene blue-photooxidized plasma: influence on coagulation and cellular contamination. Transfusion 2001 41 : 82 6.
10. Garwood M, Cardigan RA, Drummond O, Hornsey VS, Turner CP, Young D, Williamson LM, Prowse CV. The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma. Transfusion 2003 43 : 1238 47.
11. Osselaer JC, Debry C, Goffaux M, Pineau J, Calomme G, Dubuc E, Chatelain B, Vandendaele MC, Hsu J, Rheinschmidt M, Lin L. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 2008 48 : 108 17.
12. Pock K, Heger A, Janisch S, Svae TE, Römisch J. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas). Transfus Apher Sci 2007 37 : 223 31.
13. Carr ME, Jr., Powers, PL. Methylene blue enhances lateral association of fibrin resulting in rapid gelation and thick fiber formation. Thromb Haemost 1989 61 : 230 3.
14. Suontaka AM, Blomback M, Chapman J. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light. Transfusion 2003 43 : 568 75.
15. Atance R, Pereira A, Ramirez B. Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate. Transfusion 2001 41 : 1548 52.
16. Solheim BG, Cid J, Osselaer JC. Pathogen reduction technologies. In : Lozano M, Contreras M, Blajchman MA, editors. Global perspectives in transfusion medicine. 1st ed. Bethesda (MD) : AABB Press 2006. p. 103 48.
17. Lamboo M, Poland DC, Eikenboom JC, Harvey MS, Groot E, Brand A, de Vries RR. Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures. Transfus Med 2007 17 : 182 6.
18. Milam JD, Buzzurro CJ, Austin SF, Stansberry SW. Stability of factors V and VIII in thawed fresh frozen plasma units. Transfusion 1980 20 : 546 8.
19. O'Shaughnessy DF, Atterbury C, Bolton MP, Murphy M, Thomas D, Yates S, Williamson LM. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004 126 : 11 28.
20. Suontaka AM, Silveira A, Soderstrom T, Blombäck M. Occurrence of cold activation of transfusion plasma during storage at +4 degrees C. Vox Sang 2005 88 : 172 80.
21. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004 2 : 1954 9.
22. Aznar JA, Montoro JM, Cid AR, Bonanad S, Hurtado C, Soler MA, De Miguel A. Clotting factors in cryoprecipitate and cryo-supernatant prepared from MB-treated fresh plasma. Transfusion 2000 40 : 493.
23. Hornsey VS, Krailadsiri P, MacDonald S, Seghatchian J, Williamson LM, Prowse CV. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma. Br J Haematol 2000 109 : 665 70.
24. Semple E, Castrillo A, Mayo S, Eiras A, Villascusa R. Fibrin sealant prepared from methylene blue treated plasma using the cryoseal FS system: a comparative study of treated and untreated plasma. Vox Sang 2002 83 : 62.